270 related articles for article (PubMed ID: 26311840)
1. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
[TBL] [Abstract][Full Text] [Related]
2. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
[TBL] [Abstract][Full Text] [Related]
3. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.
Muñoz P; Vena A; Machado M; Gioia F; Martínez-Jiménez MC; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Fernández-Ruiz M; Merino P; González-Romo F; Frías I; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv6-iv12. PubMed ID: 29608751
[TBL] [Abstract][Full Text] [Related]
4. Candida biomarkers in patients with candidaemia and bacteraemia.
Martínez-Jiménez MC; Muñoz P; Valerio M; Alonso R; Martos C; Guinea J; Bouza E
J Antimicrob Chemother; 2015 Aug; 70(8):2354-61. PubMed ID: 25900160
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
[TBL] [Abstract][Full Text] [Related]
6. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Ubeda A; Loza A; Martín-Mazuelos E; Blanco A; Jerez V; Ballús J; Alvarez-Rocha L; Utande-Vázquez A; Fariñas O
Intensive Care Med; 2012 Aug; 38(8):1315-25. PubMed ID: 22752333
[TBL] [Abstract][Full Text] [Related]
7. Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 → 3)-β-D-glucan (BDG) for diagnosis of invasive candidiasis (IC).
Pini P; Colombari B; Marchi E; Castagnoli A; Venturelli C; Sarti M; Blasi E
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):39-43. PubMed ID: 30098849
[No Abstract] [Full Text] [Related]
8. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
[TBL] [Abstract][Full Text] [Related]
9. (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.
Posteraro B; Tumbarello M; De Pascale G; Liberto E; Vallecoccia MS; De Carolis E; Di Gravio V; Trecarichi EM; Sanguinetti M; Antonelli M
J Antimicrob Chemother; 2016 Aug; 71(8):2262-9. PubMed ID: 27125554
[TBL] [Abstract][Full Text] [Related]
10. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study).
Ramos JT; Villar S; Bouza E; Bergon-Sendin E; Perez Rivilla A; Collados CT; Andreu M; Reyes CS; Campos-Herrero MI; de Heredia JL; Herrera MCL; Alonso PA; Pallás-Alonso CR; Cuenca-Estrella M;
J Clin Microbiol; 2017 Sep; 55(9):2752-2764. PubMed ID: 28659321
[TBL] [Abstract][Full Text] [Related]
11. Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.
Pemán J; Zaragoza R; Quindós G; Alkorta M; Cuétara MS; Camarena JJ; Ramírez P; Giménez MJ; Martín-Mazuelos E; Linares-Sicilia MJ; Pontón J;
BMC Infect Dis; 2011 Mar; 11():60. PubMed ID: 21388550
[TBL] [Abstract][Full Text] [Related]
12. Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial.
Rouzé A; Loridant S; Poissy J; Dervaux B; Sendid B; Cornu M; Nseir S;
Intensive Care Med; 2017 Nov; 43(11):1668-1677. PubMed ID: 28936678
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic surveillance by Candida albicans germ tube antibody in intensive care unit patients.
Trovato L; Astuto M; Castiglione G; Scalia G; Oliveri S
J Microbiol Immunol Infect; 2020 Oct; 53(5):778-784. PubMed ID: 30902614
[TBL] [Abstract][Full Text] [Related]
14. β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
Hanson KE; Pfeiffer CD; Lease ED; Balch AH; Zaas AK; Perfect JR; Alexander BD
PLoS One; 2012; 7(8):e42282. PubMed ID: 22879929
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis.
Guo J; Wu Y; Lai W; Lu W; Mu X
BMC Infect Dis; 2019 Aug; 19(1):716. PubMed ID: 31412796
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients.
Díez A; Carrano G; Bregón-Villahoz M; Cuétara MS; García-Ruiz JC; Fernandez-de-Larrinoa I; Moragues MD
Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115509. PubMed ID: 34384954
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
[TBL] [Abstract][Full Text] [Related]
18. Candida albicans Germ-Tube Antibody: Evaluation of a New Automatic Assay for Diagnosing Invasive Candidiasis in ICU Patients.
Parra-Sánchez M; Zakariya-Yousef Breval I; Castro Méndez C; García-Rey S; Loza Vazquez A; Úbeda Iglesias A; Macías Guerrero D; Romero Mejías A; León Gil C; Martín-Mazuelos E;
Mycopathologia; 2017 Aug; 182(7-8):645-652. PubMed ID: 28378240
[TBL] [Abstract][Full Text] [Related]
19. Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
Liew YX; Teo J; Too IA; Ngan CC; Tan AL; Chlebicki MP; Kwa AL; Lee W
BMC Infect Dis; 2015 Jul; 15():256. PubMed ID: 26137997
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients.
Pazos C; Moragues MD; Quindós G; Pontón J; del Palacio A
Rev Iberoam Micol; 2006 Dec; 23(4):209-15. PubMed ID: 17388644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
